Evidence map›Paper›PMID 29961568›Full record

ArticleAmerican journal of human genetics2018

De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures.

Yoko Ito, Keren J Carss, Sofia T Duarte, Taila Hartley, Boris Keren, Manju A Kurian, Isabelle Marey, Perinne Charles, Carla Mendonça, Caroline Nava and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 47 citations in OpenAlex.

  1. ARP2/3 complex mediates the neuropathology of PTEN-deficient human neural cells downstream of mTORC1 and mTORC2 hyperactivation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. An asymptomaticFrontiers in behavioral neuroscience · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Saudi journal of biological sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 12 institutions in 5 countries.

Yoko ItoChildren's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON K1H 8L1 Canada.
Keren J CarssDepartment of Haematology, University of Cambridge, Cambridge CB2 0PT, UK; NIHR BioResource, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.
Sofia T DuarteHospital Dona Estefânia, Centro Hospitalar de Lisboa Central, 1169-045 Lisbon, Portugal.
Taila HartleyChildren's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON K1H 8L1 Canada.
Boris KerenDépartement de Génétique et Centre de Référence Déficiences Intellectuelles de Causes Rares, Hôpital de la Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris, 75651 Paris, France.
Manju A KurianDevelopmental Neurosciences, Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.
Isabelle MareyDépartement de Génétique et Centre de Référence Déficiences Intellectuelles de Causes Rares, Hôpital de la Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris, 75651 Paris, France.
Perinne CharlesDépartement de Génétique et Centre de Référence Déficiences Intellectuelles de Causes Rares, Hôpital de la Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris, 75651 Paris, France.
Carla MendonçaCentro de Neuropediatria e Desenvolvimento, Centro Hospitalar Universitário do Algarve, Faro 8000, Portugal.
Caroline NavaDépartement de Génétique et Centre de Référence Déficiences Intellectuelles de Causes Rares, Hôpital de la Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris, 75651 Paris, France; Sorbonne Universités, Université Pierre et Marie Curie, Paris 75013, France.
Rolph PfundtDepartment of Human Genetics, Radboudumc, Donders Institute for Brain, Cognition, and Behaviour, Box 9101, 6500 HB Nijmegen, the Netherlands.
Alba Sanchis-JuanDepartment of Haematology, University of Cambridge, Cambridge CB2 0PT, UK; NIHR BioResource, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.
Hans van BokhovenDepartment of Human Genetics, Radboudumc, Donders Institute for Brain, Cognition, and Behaviour, Box 9101, 6500 HB Nijmegen, the Netherlands.
Anthony van EssenUniversity of Groningen, University Medical Centre Groningen, Department of Genetics, P.O. Box 30.001, 9700 RB Groningen, the Netherlands.
Conny van Ravenswaaij-ArtsUniversity of Groningen, University Medical Centre Groningen, Department of Genetics, P.O. Box 30.001, 9700 RB Groningen, the Netherlands.
NIHR BioResource
Care4Rare Canada Consortium
Kym M BoycottChildren's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON K1H 8L1 Canada; Department of Genetics, Children's Hospital of Eastern Ontario, Ottawa, ON K1H 8L1, Canada.
Kristin D KernohanChildren's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON K1H 8L1 Canada.
Sarah DyackDepartment of Pediatrics, Dalhousie University, Halifax, NS B3K 6R8, Canada.
F Lucy RaymondNIHR BioResource, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK; Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK. Electronic address: flr24@cam.ac.uk.
Dalhousie University · CAUniversity of Ottawa · CACambridge University Hospitals NHS Foundation Trust · GBRadboud University Nijmegen · NLUniversity Medical Center Groningen · NLSorbonne Université · FRUniversity of Cambridge · GBChildren's Hospital of Eastern Ontario · CAUnidade Local de Saúde de São José · PTUniversity College London · GBAssistance Publique – Hôpitaux de Paris · FRUnité de recherche sur les maladies cardiovasculaires et métaboliques · FR

Funding

British Heart Foundation FS/10/013/28073British Heart Foundation PG/15/103/31900Department of Health RP-2016-07-019Medical Research Council G0800671Medical Research Council G84/6443Medical Research Council MC_UU_00002/10Medical Research Council MR/J011711/1Medical Research Council MR/L006340/1
6 · The paper itself

Abstract

Next-generation sequencing has been invaluable in the elucidation of the genetic etiology of many subtypes of intellectual disability in recent years. Here, using exome sequencing and whole-genome sequencing, we identified three de novo truncating mutations in WAS protein family member 1 (WASF1) in five unrelated individuals with moderate to profound intellectual disability with autistic features and seizures. WASF1, also known as WAVE1, is part of the WAVE complex and acts as a mediator between Rac-GTPase and actin to induce actin polymerization. The three mutations connected by Matchmaker Exchange were c.1516C>T (p.Arg506Ter), which occurs in three unrelated individuals, c.1558C>T (p.Gln520Ter), and c.1482delinsGCCAGG (p.Ile494MetfsTer23). All three variants are predicted to partially or fully disrupt the C-terminal actin-binding WCA domain. Functional studies using fibroblast cells from two affected individuals with the c.1516C>T mutation showed a truncated WASF1 and a defect in actin remodeling. This study provides evidence that de novo heterozygous mutations in WASF1 cause a rare form of intellectual disability.

Indexed as

AdultExome SequencingFemaleHeterozygoteHumansIntellectual DisabilityMaleMutationSeizuresWiskott-Aldrich Syndrome Protein FamilyYoung AdultWASF1 protein, humanWiskott-Aldrich Syndrome Protein Familyactin cytoskeletonautismdevelopmental delaylamellipodianeurodevelopmental disorderrecurrent de novo truncating mutationsseizuresWASF1WAVE1 complex

Identifiers

PMID29961568
PMCPMC6037130
OpenAlexW2810862321

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.